Page last updated: 2024-08-25

zoledronic acid and Thrombocytopenia

zoledronic acid has been researched along with Thrombocytopenia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Karpuz, S	1
Hamersky, J; Jimenez, PT; Neto, RLALT; Smith, AA; Soileau, AM	1
Cushman, T; Donthireddy, V; Kulkarni, P; Rao, S	1
Chahine, GY; Farhat, FS; Ghosn, MG; Kattan, JG; Moukadem, WT; Nasr, FL; Yazbeck, NJ; Younes, FC	1

Trials

1 trial(s) available for zoledronic acid and Thrombocytopenia

Article	Year
Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC). Investigational new drugs, 2008, Volume: 26, Issue:1 Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Fatigue; Humans; Hypocalcemia; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Zoledronic Acid	2008

Article

Year

Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC).

Investigational new drugs, 2008, Volume: 26, Issue:1

Topics: Administration, Oral; Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Diphosphonates; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Estramustine; Fatigue; Humans; Hypocalcemia; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids; Thrombocytopenia; Time Factors; Treatment Outcome; Zoledronic Acid

2008

Other Studies

3 other study(ies) available for zoledronic acid and Thrombocytopenia

Article	Year
Zoledronic acid-induced severe lymphopenia. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2023, Volume: 34, Issue:9 Topics: Acute-Phase Reaction; Anemia; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Lymphopenia; Male; Osteoporosis; Thrombocytopenia; Zoledronic Acid	2023
Doxorubicin and zoledronate treatment in a dog with hemophagocytic histiocytic sarcoma. The Canadian veterinary journal = La revue veterinaire canadienne, 2023, Volume: 64, Issue:12 Topics: Animals; Dog Diseases; Dogs; Doxorubicin; Histiocytic Sarcoma; Hyperbilirubinemia; Hypoalbuminemia; Lomustine; Male; Thrombocytopenia; Zoledronic Acid	2023
Spontaneously recovered severe thrombocytopaenia following zoledronic acid infusion for osteoporosis. BMJ case reports, 2016, Feb-03, Volume: 2016 Topics: Aged; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Osteoporosis; Platelet Count; Remission, Spontaneous; Thrombocytopenia; Zoledronic Acid	2016